Vapotherm, Inc. announced the appointment of Brian Lawrence as Senior Vice President and Chief Technology Officer, effective immediately. Prior to joining Vapotherm, Mr. Lawrence, age 52, served as Chief Technology Officer & General Manager of Gravity Diagnostics, LLC, a diagnostics company, where he was responsible for technology and innovation programs across the company. Prior to joining Gravity Diagnostics, Mr. Lawrence served as Senior Vice President & Chief Technology Officer of Hillrom Holdings, Inc. (“Hillrom”), a medical device company, from 2010 to 2021. While at Hillrom, Mr. Lawrence was responsible for global technology and innovation teams of over 800 employees in seven countries and an annual budget of $150 million. He led a digital transformation for the company and created a new SaaS business valued at over $100 million. Prior to that position, he served as Chief Technology Officer of Life Support Solutions, a division of GE Healthcare, where he was responsible for global engineering teams of over 400 employees across the US, Europe, and Asia with a budget of over $70 million annually. On December 6, 2021, Vapotherm announced the appointment of Dorota McKay as Controller and Chief Accounting Officer, effective immediately. Prior to joining Vapotherm, Ms. McKay, age 39, served as Controller of Decibel Therapeutics, Inc., a clinical-stage biotechnology company, from March 2021 to November 2021. Prior to that position, Ms. McKay served as Finance Director, Accounting & Process Improvement, of Oxford Immunotec Global PLC, a global diagnostics company recently acquired by PerkinElmer, Inc., where she oversaw the United States accounting, internal audit and tax functions, from April 2019 to March 2021. Prior to that position, she served as Senior Manager, Internal Audit from April 2018 to April 2019, and Financial Reporting Manager from July 2016 to March 2018. Prior to her time at Oxford Immunotec, Ms. McKay held various positions, including Internal Audit Manager for Altra Industrial Motion Corp. from December 2015 to July 2016, Assurance Staff and Senior for EY from September 2013 to December 2015, and Staff and Senior Auditor for Macpage LLC from January 2012 to September 2013. As a result of Ms. McKay’s appointment, John Landry, Vapotherm’s Senior Vice President & Chief Financial Officer, will no longer serve as company’s principal accounting officer.
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
VAPOTHERM, INC. 
